Anti-AGRE3/ ADGRE3/ EMR3 monoclonal antibody

Anti-AGRE3/ ADGRE3/ EMR3 antibody for FACS & in-vivo assay

Target products collectionGo to ADGRE3/ADGRE3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2589-Ab-1/ GM-Tg-hg-MP2589-Ab-2Anti-Human ADGRE3 monoclonal antibodyHuman
GM-Tg-rg-MP2589-Ab-1/ GM-Tg-rg-MP2589-Ab-2Anti-Rat ADGRE3 monoclonal antibodyRat
GM-Tg-mg-MP2589-Ab-1/ GM-Tg-mg-MP2589-Ab-2Anti-Mouse ADGRE3 monoclonal antibodyMouse
GM-Tg-cynog-MP2589-Ab-1/ GM-Tg-cynog-MP2589-Ab-2Anti-Cynomolgus/ Rhesus macaque ADGRE3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2589-Ab-1/ GM-Tg-felg-MP2589-Ab-2Anti-Feline ADGRE3 monoclonal antibodyFeline
GM-Tg-cang-MP2589-Ab-1/ GM-Tg-cang-MP2589-Ab-2Anti-Canine ADGRE3 monoclonal antibodyCanine
GM-Tg-bovg-MP2589-Ab-1/ GM-Tg-bovg-MP2589-Ab-2Anti-Bovine ADGRE3 monoclonal antibodyBovine
GM-Tg-equg-MP2589-Ab-1/ GM-Tg-equg-MP2589-Ab-2Anti-Equine ADGRE3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2589-Ab-1/ GM-Tg-hg-MP2589-Ab-2; GM-Tg-rg-MP2589-Ab-1/ GM-Tg-rg-MP2589-Ab-2;
GM-Tg-mg-MP2589-Ab-1/ GM-Tg-mg-MP2589-Ab-2; GM-Tg-cynog-MP2589-Ab-1/ GM-Tg-cynog-MP2589-Ab-2;
GM-Tg-felg-MP2589-Ab-1/ GM-Tg-felg-MP2589-Ab-2; GM-Tg-cang-MP2589-Ab-1/ GM-Tg-cang-MP2589-Ab-2;
GM-Tg-bovg-MP2589-Ab-1/ GM-Tg-bovg-MP2589-Ab-2; GM-Tg-equg-MP2589-Ab-1/ GM-Tg-equg-MP2589-Ab-2
Products NameAnti-ADGRE3 monoclonal antibody
Formatmab
Target NameADGRE3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ADGRE3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species AGRE3/ ADGRE3/ EMR3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2589
    Target NameADGRE3
    Gene ID84658,52614,106994649,484900,101098285,526347,100064825
    Gene Symbol and SynonymsADGRE3,Adgre4,D17Ertd479e,Egf-tm7,EMR3,Emr4,Fire,Gpr127
    Uniprot AccessionQ9BY15
    Uniprot Entry NameAGRE3_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000131355
    Target ClassificationGPCR

    The target: ADGRE3, gene name: ADGRE3, also named as EMR3. This gene encodes a member of the class B seven-span transmembrane (™7) receptor family expressed predominantly by cells of the immune system. Family members are characterized by an extended extracellular region with a variable number of N-terminal epidermal growth factor (EGF)-like domains coupled to a ™7 domain via a mucin-like spacer domain. This gene is closely linked to the gene encoding egf-like molecule containing mucin-like hormone receptor 2 on chromosome 19. This protein may play a role in myeloid-myeloid interactions during immune and inflammatory responses. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.